IGF-1 DES (1-3)
des-igf igf des
Truncated short-acting IGF-1 variant. Site-specific activity; bodybuilding research context.
- Half-life
- 18 min
- Out of system
- ~2 h
- Route
- Subcutaneous
- Level
- Advanced
Very short-acting — protocols dose 1–2× a day. After the last dose, roughly 97% has cleared in ~2 h (five half-lives) — the window that matters for washouts, bloodwork and surgery.
What IGF-1 DES (1-3) is used for
- Truncated short-acting IGF-1 — strong local muscle signaling
- Used post-workout in bodybuilding research contexts
How it's typically used
Research range: ~50 mcg subcutaneous post-workout (local).
What to watch for
- Hypoglycemia risk — keep carbs handy
- Theoretical cancer-growth concern
- Advanced compound; sourcing and dosing precision matter
Common questions
- What is the half-life of IGF-1 DES (1-3)?
- IGF-1 DES (1-3) has an approximate elimination half-life of 18 min. Very short-acting — protocols dose 1–2× a day.
- How long does IGF-1 DES (1-3) stay in your system?
- Roughly 97% of a dose has cleared after five half-lives — about ~2 h for IGF-1 DES (1-3). That is the window that matters for washouts, bloodwork and surgery.
- How is IGF-1 DES (1-3) taken?
- IGF-1 DES (1-3) is typically administered by the subcutaneous route. Research range: ~50 mcg subcutaneous post-workout (local).
- What are the risks of IGF-1 DES (1-3)?
- Hypoglycemia risk — keep carbs handy Theoretical cancer-growth concern Advanced compound; sourcing and dosing precision matter
About Performance & GH
- What they are
- Growth-hormone secretagogues and related performance compounds. Rather than supplying GH, they push your pituitary to release more of its own in a pulse.
- How they're run
- Subcutaneous injection, most often at night on an empty stomach so the pulse lands with natural sleep-driven GH release.
- What to watch
- Water retention, tingling hands, and hunger swings are the common early signs. Raising GH raises IGF-1 — worth tracking on bloodwork, and a reason to avoid these with any cancer history.
Full guide
IGF-1 DES (1-3): A Tracking Guide for a Truncated IGF Variant
A short-acting IGF-1 variant used in research and bodybuilding circles. Here is how to track it honestly.
Other performance & gh
Peptid AI is an educational and self-tracking tool — not a medical service, and not a vendor. Nothing here is medical advice, a prescription, or an endorsement. Doses reflect what is commonly reported in research literature; they are not recommendations. Many compounds listed are experimental, not approved for human use, and/or controlled substances that are illegal to possess without a prescription in many countries. Always consult a qualified physician before starting, changing, or stopping any protocol.